Abstract:The development of BINOL-derived Brønsted acid catalysts has been profoundly guided by rational design, with carefully implemented structural changes leading to unique generations of catalysts with enhanced reaction capabilities. This approach to catalyst optimization has promoted the integration of knowledge gathered in optimizing prior eras of Brønsted acids and ultimately, the molecular features that have contributed to the success of previous designs are preserved. Of these, the large substituents at the 3 and 3’ positions of the BINOL backbone are the most critical with almost every newly developed structure possessing this feature. However, imidodiphosphorimidate (IDPi) catalysts are not synthetically well-suited to contain the same sterically bulky groups associated with the high selectivity imparted by previously implemented catalyst structures. Herein, we have leveraged the moderate size (as compared to TRIP and 9-anthryl) but high applicability of the 9-phenanthryl substituent to synthesize a sterically demanding IDPi. Using computed descriptors, we survey the catalyst properties of known structures to demonstrate this catalyst to be both unique and one of the bulkiest IDPi yet synthesized. The applicability of the catalyst was evaluated in the construction of stereochemically dense spirocycles generated via an asymmetric Prins-semipinacol reaction sequence. Transition state calculations were deployed to interrogate the origins of the superior enantioselectivity and these demonstrate the mechanistic hallmarks of the 9-phenanthryl substituent can be generalized to a genuinely different class of Brønsted acid catalyst. Ultimately, providing the basis for the development of general catalyst design principles and the translation of “privileged” substituents across unique eras of Brønsted acid catalyst structures.

Pinene-derived Iminodiacetic Acid (PIDA): a Powerful Ligand for Stereoselective Synthesis and Iterative Cross-Coupling of C(sp3) Boronate Building Blocks.

Enantioselective Synthesis Of Axially Chiral Biaryls Via Cu-Catalyzed Acyloxylation Of Cyclic Diaryliodonium Salts

Stereospecific Csp3 Suzuki–Miyaura Cross-Coupling That Evades Β-Oxygen Elimination

Application of Pinacolborane in Catalytic Enantioselective Hydroboration of Ketones and Imines

Cobalt-Catalyzed Asymmetric Sequential Hydroboration/Hydrogenation of Internal Alkynes

Enantio‐ and Regioselective Cascade Hydroboration of Methylenecyclopropanes for Facile Access to Chiral 1,3‐ and 1,4‐Bis(boronates)

Iridium-Catalyzed Enantioselective C–H Borylation of Diarylphosphinates

Controllable Regio- and Stereo-Selective Coupling Reactions of Homoallenylboronates

Carbene‐catalyzed and Pnictogen Bond‐assisted Access to PIII‐Stereogenic Compounds

Enantioselective Synthesis of β-Aminoboronic Acids via Borylalkylation of Enamides

Regioselective Electrophilic Addition to Propargylic B(MIDA)s Enabled by β‐Boron Effect

Synthesis of a C2-Symmetric Chiral Borinic Acid and Its Application in Catalytic Desymmetrization of 2,2-Disubstituted-1,3-propanediols

Iron-Catalyzed Borylation of Propargylic Acetates for the Synthesis of Multisubstituted Allenylboronates

Bi(III)-Catalyzed Enantioselective Allylation Reactions of Ketimines

Enantioconvergent synthesis of axially chiral amides enabled by Pd-catalyzed dynamic kinetic asymmetric aminocarbonylation

Asymmetric Synthesis of Chiral-at-P Alkenylphosphonamidates through Nickel-Catalyzed C-P Coupling of Phosphoramidites and Alkenyl Halides

A Bulky Imidodiphosphorimidate Brønsted Acid Enables Highly Enantioselective Prins-semipinacol Rearrangements

Pd-Catalyzed Enantioselective Syntheses of Trisubstituted Allenes Via Coupling of Propargylic Benzoates with Organoboronic Acids.

Regio- and Stereoselective Synthesis of Multi-Alkylated Allylic Boronates through Three-Component Coupling Reactions between Allenes, Alkyl Halides, and a Diboron Reagent

Chiral Phosphoric Acid-Catalyzed Remote Control of Axial Chirality at Boron–Carbon Bond

Photoinduced Site-Selective Aryl C-H Borylation with Electron-Donor-Acceptor Complex Derived from B2Pin2 and Isoquinoline